CY2007009I2 - Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου - Google Patents

Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου

Info

Publication number
CY2007009I2
CY2007009I2 CY2007009C CY2007009C CY2007009I2 CY 2007009 I2 CY2007009 I2 CY 2007009I2 CY 2007009 C CY2007009 C CY 2007009C CY 2007009 C CY2007009 C CY 2007009C CY 2007009 I2 CY2007009 I2 CY 2007009I2
Authority
CY
Cyprus
Prior art keywords
virus
pamma
disassembled
particles
human
Prior art date
Application number
CY2007009C
Other languages
English (en)
Other versions
CY2007009I1 (el
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26824774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2007009(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of CY2007009I1 publication Critical patent/CY2007009I1/el
Publication of CY2007009I2 publication Critical patent/CY2007009I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY2007009C 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου CY2007009I2 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12652899P 1999-03-26 1999-03-26
US09/524,624 US6245568B1 (en) 1999-03-26 2000-03-13 Human papilloma virus vaccine with disassembled and reassembled virus-like particles
PCT/US2000/007595 WO2000057906A1 (en) 1999-03-26 2000-03-22 Human papillomavirus vaccine with disassembled and reassembled virus-like particles

Publications (2)

Publication Number Publication Date
CY2007009I1 CY2007009I1 (el) 2010-07-28
CY2007009I2 true CY2007009I2 (el) 2010-07-28

Family

ID=26824774

Family Applications (4)

Application Number Title Priority Date Filing Date
CY20061101649T CY1105779T1 (el) 1999-03-26 2006-11-14 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY2007009C CY2007009I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY200700010C CY2007010I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY200700008C CY2007008I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20061101649T CY1105779T1 (el) 1999-03-26 2006-11-14 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου

Family Applications After (2)

Application Number Title Priority Date Filing Date
CY200700010C CY2007010I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
CY200700008C CY2007008I2 (el) 1999-03-26 2007-03-16 Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου

Country Status (19)

Country Link
US (2) US6245568B1 (el)
EP (1) EP1165126B1 (el)
JP (1) JP4594534B2 (el)
KR (1) KR20020013516A (el)
AR (1) AR023166A1 (el)
AT (1) ATE339222T1 (el)
AU (1) AU778937B2 (el)
CA (1) CA2368391C (el)
CY (4) CY1105779T1 (el)
DE (4) DE122007000032I1 (el)
DK (1) DK1165126T3 (el)
ES (1) ES2270822T3 (el)
FR (1) FR07C0026I2 (el)
LT (1) LTC1165126I2 (el)
LU (3) LU91326I2 (el)
NL (3) NL300268I1 (el)
PT (1) PT1165126E (el)
SI (1) SI1165126T1 (el)
WO (1) WO2000057906A1 (el)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962777B1 (en) * 1997-09-05 2005-11-08 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
US7351533B2 (en) 1997-09-05 2008-04-01 Medimmune, Inc. In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
DE60041889D1 (de) * 1999-12-09 2009-05-07 Medimmune Inc In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
RU2323002C2 (ru) * 2001-07-26 2008-04-27 Чирон Срл. Вакцины, содержащие алюминиевые адъюванты и гистидин
DE10137102A1 (de) * 2001-07-30 2003-02-27 Deutsches Krebsforsch Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
AU2003219760A1 (en) * 2002-02-14 2003-09-04 Novavax, Inc. Optimization of gene sequences of virus-like particles for expression in insect cells
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
DE10237639A1 (de) * 2002-08-13 2004-02-26 Martin-Luther-Universität Halle-Wittenberg Verfahren zur Herstellung von virusanalogen Partikeln durch in vitro-Assemblierung von Kapsomeren oder von Kapsomeren, an die biologisch aktive Makromoleküle gebunden sind, bei gleichzeitiger Verpackung der Makromoleküle
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
ES2280809T3 (es) 2002-11-01 2007-09-16 Glaxosmithkline Biologicals S.A. Composicion inmunogenica.
US7858098B2 (en) * 2002-12-20 2010-12-28 Glaxosmithkline Biologicals, S.A. Vaccine
AP2005003347A0 (en) 2002-12-20 2005-06-30 Glayosmithkline Biolog S A HPV-16 and-18 Lu VLP vaccine
EP1785433A4 (en) * 2004-07-01 2008-10-01 Tokyo Inst Tech VIRUS PARTICULAR CONSTRUCT AND METHOD FOR THEIR EDUCATION UNDER PHYSIOLOGICAL CONDITIONS
TW200634145A (en) * 2005-01-25 2006-10-01 Wyeth Res Ireland Ltd Shear protectants in harvest microfiltration
US7759104B2 (en) * 2005-07-14 2010-07-20 Mayo Foundation For Medical Education And Research Paramyxoviridae virus preparations
CA2618439A1 (en) * 2005-08-12 2007-02-22 Astellas Pharma Inc. Technique for stabilization of yw753 reparation
CN101291689B (zh) * 2005-09-01 2012-12-05 若泽·路易斯·努诺·阿雅拉 用于大规模接种系统的活抗原的疫苗稳定化制剂
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
US8962262B2 (en) * 2006-05-11 2015-02-24 Arbor Vita Corporation Method of protein extraction from cells
US9207240B2 (en) * 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
EP2258380B1 (en) * 2008-03-31 2013-03-13 Morinaga Milk Industry Co., Ltd. Nucleic acid for imparting heat resistance to lactoferrin
BR112012004699B1 (pt) 2009-09-03 2019-10-15 Becton, Dickinson And Company Métodos, composições e kits para lise química direta
HRP20210242T4 (hr) 2010-08-23 2024-05-10 Wyeth Llc Stabilne formulacije antigena iz bakterije neisseria meningitidis rlp2086
CN103096920B (zh) 2010-09-10 2016-03-23 惠氏有限责任公司 脑膜炎奈瑟球菌orf2086抗原的非脂质化变体
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
BR122016004924A2 (pt) 2012-03-09 2019-07-30 Pfizer Inc. Polipeptídeo isolado e composições imunogênicas compreendendo os mesmos
WO2013139744A1 (en) 2012-03-18 2013-09-26 Glaxosmithkline Biologicals S.A. Method of vaccination against human papillomavirus
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
JP6446377B2 (ja) 2013-03-08 2018-12-26 ファイザー・インク 免疫原性融合ポリペプチド
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
AU2016221318B2 (en) 2015-02-19 2020-06-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
AU2018215585B2 (en) 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
US20200010850A1 (en) 2017-02-17 2020-01-09 The USA, as represeented by the Secretary, Dept. of Health and Human Services Efficient cell free production of papillomavirus gene transfer vectors
CN110987571A (zh) * 2019-12-31 2020-04-10 广州金域医学检验中心有限公司 一种单克隆多聚体m蛋白解聚方法
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE470434T1 (de) * 1997-02-06 2010-06-15 Merck Sharp & Dohme Thimerosal-freie konservierungsmittel für impfstoffe
KR20010006169A (ko) 1997-04-08 2001-01-26 폴락 돈나 엘. 안정화된 사람 파필로마바이러스 제형물
EP1000157A1 (en) 1997-07-03 2000-05-17 University Technology Corporation Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy

Also Published As

Publication number Publication date
US20010021385A1 (en) 2001-09-13
LU91326I9 (el) 2018-12-31
FR07C0026I1 (el) 2007-04-27
NL300270I1 (nl) 2007-05-01
DE122007000033I1 (de) 2007-08-09
LU91328I9 (el) 2019-03-01
LU91327I9 (el) 2019-03-01
CY2007010I1 (el) 2009-11-04
LU91326I2 (fr) 2007-05-14
US6245568B1 (en) 2001-06-12
AR023166A1 (es) 2002-09-04
CY2007010I2 (el) 2009-11-04
KR20020013516A (ko) 2002-02-20
CA2368391A1 (en) 2000-10-05
CY2007008I1 (el) 2009-11-04
EP1165126A1 (en) 2002-01-02
DK1165126T3 (da) 2007-01-08
DE60030698T2 (de) 2007-07-19
DE122007000034I1 (de) 2007-08-09
DE122007000032I1 (de) 2007-08-09
CY2007009I1 (el) 2010-07-28
NL300268I1 (nl) 2007-05-01
LTC1165126I2 (lt) 2020-04-27
FR07C0026I2 (fr) 2012-08-03
ATE339222T1 (de) 2006-10-15
CY1105779T1 (el) 2010-07-28
LU91327I2 (fr) 2007-05-14
LTPA2007002I1 (lt) 2020-03-25
AU3909300A (en) 2000-10-16
SI1165126T1 (sl) 2006-12-31
CY2007008I2 (el) 2009-11-04
JP4594534B2 (ja) 2010-12-08
NL300269I1 (nl) 2007-05-01
ES2270822T3 (es) 2007-04-16
DE60030698D1 (de) 2006-10-26
WO2000057906A1 (en) 2000-10-05
PT1165126E (pt) 2006-12-29
LU91328I2 (fr) 2007-05-14
AU778937B2 (en) 2004-12-23
CA2368391C (en) 2011-06-07
NL300269I2 (nl) 2008-07-01
JP2002540167A (ja) 2002-11-26
EP1165126B1 (en) 2006-09-13

Similar Documents

Publication Publication Date Title
CY2007009I2 (el) Εμβολιο ανθρωπινου ιου θηλωματων με αποσυγκροτημενα και επανασυγκροτημενα σωματιδια ομοιαζοντα με αυτα του ιου
ATE414533T1 (de) Impfstoff gegen hbv und hpv
DE60024893D1 (de) Impfstoff gegen HPV
DE60040727D1 (de) Menschliche papillomavirus impfstoff-formulierungen
CY2016021I1 (el) Στελεχη ιων για την ογκολυτικη θεραπεια του καρκινου
NO20004104L (no) Preparater omfattende virus og fremgangsmater for konsentrering av viruspreparater
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
DE60038166D1 (de) Impfstoff gegen bakterielle antigene
HK1083454A1 (en) Recombinant vaccine viruses expressing il-15 and methods of using the same 15(il-15)
AU2003227533A8 (en) Virus like particle from papillomavirus and their use in vaccine
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
FR2843964B1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
MA27233A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
EP1694694A4 (en) REPLICATION COMPETENT HEPATITIS C-VIRUS AND METHOD OF USE
DE50213084D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
NO20033829L (no) Virusdrepende preparater
EP1389043A4 (en) VACCINE AGAINST THE MOUSE AND CLAUS ACID VIRUS
FR2862967B1 (fr) Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique
DE69934108D1 (de) Kombinierte Impfstoffe gegen Hepatitis A und Hepatitis B
FR2842527B1 (fr) Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
PT1253197E (pt) Virus da raiva recombinante atenuado e suas vacinas vivas
DE60125927D1 (de) Impfstoffe gegen hiv
IS2797B (is) Bóluefni gegn ISA-veiru